Top compounds associated with response to ADAM2


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.056 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.031 0.5
mRNA tivozanib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.026 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.056 0.08
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.0059 0.9
mRNA triptolide CTRPv2 pan-cancer AAC 0.057 0.1
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.081 0.1
Download CSV